Triple

T19730320
Position Surface form Disambiguated ID Type / Status
Subject Lesath E473832 entity
Predicate catalogIdentifier P8090 FINISHED
Object CD−37 11636
CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
E1392581 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CD−37 11636 | Statement: [Lesath, catalogIdentifier, CD−37 11636]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: CD−37 11636
Context triple: [Lesath, catalogIdentifier, CD−37 11636]
  • A. CD−59 4504
    CD−59 4504 is a catalog designation for Beta Crucis, a bright blue giant star in the constellation Crux.
  • B. CD−45 13193
    CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
  • C. CD21
    CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
  • D. CD19
    CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
  • E. CD38
    CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: CD−37 11636
Triple: [Lesath, catalogIdentifier, CD−37 11636]
Generated description
CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: CD−37 11636
Target entity description: CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
  • A. CD−59 4504
    CD−59 4504 is a catalog designation for Beta Crucis, a bright blue giant star in the constellation Crux.
  • B. CD−45 13193
    CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
  • C. CD21
    CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
  • D. CD19
    CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
  • E. CD38
    CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e517ebd48190979ee76723bcfadf completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e649fbeaf081909e9356229eaf84dd completed April 20, 2026, 3:45 p.m.
NED1 Entity disambiguation (via context triple) batch_6a07b4f2de3481909b3402e5d3e7af2a completed May 16, 2026, 12:06 a.m.
NEDg Description generation batch_6a07b62186cc81908f471747261b60a9 completed May 16, 2026, 12:11 a.m.
NED2 Entity disambiguation (via description) batch_6a07b6e4ae348190a3783c6a82059793 completed May 16, 2026, 12:14 a.m.
Created at: April 10, 2026, 1:47 p.m.